The exact same number of priBlCa-1 primary bladder cancer cells (six million cells per mouse) with the CRISPR/Cas9-TIMM44-KO construct (“KO-TIMM44”, see Fig. 5) or the CRISPR/Cas9-KO control construct (“KO-C”, see Fig. 5) were s.c. Here, TIMM44 is linked to urinary bladder carcinoma.